Medindia

X

Prevalence of BRAF Mutations in Thyroid Cancers Makes Them a Therapeutic Target

by Kathy Jones on  November 24, 2011 at 5:57 PM Cancer News   - G J E 4
The most common form of thyroid cancer is known as papillary carcinoma. Research has shown that approximately one quarter of these carcinomas have mutations in the BRAF gene.
 Prevalence of BRAF Mutations in Thyroid Cancers Makes Them a Therapeutic Target
Prevalence of BRAF Mutations in Thyroid Cancers Makes Them a Therapeutic Target
Advertisement

The prevalence of such mutations is even greater in high-grade carcinomas, particularly those that are refractory to standard treatment, which is radioactive iodine (RAI). A team of researchers led by James Fagin, at Memorial Sloan-Kettering Cancer Center, New York, has now identified a way to potentially exploit the expression of BRAF by such cancers for therapeutic purposes.

Advertisement
Despite the prevalence of BRAF mutations in papillary carcinoma it has remained unclear how dependent thyroid cancers are on BRAF expression. Fagin and colleagues first showed that thyroid tumors in mice expressing one of the most commonly detected BRAF mutations in human papillary thyroid carcinomas were exquisitely dependent on BRAF for viability. Of therapeutic significance, treating thyroid tumor-bearing mice with drugs that inhibited the BRAF signaling pathway rendered the tumor cells susceptible to a therapeutic dose of RAI. Fagin and colleagues therefore suggest that their data provide rationale for clinical trials testing whether such drugs can restore the efficacy of RAI therapy in patients with papillary thyroid carcinomas expressing BRAF mutations.



Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All